BRPI0909752A2 - método para a produção de sulfonilpirróis como inibidores de hdac - Google Patents

método para a produção de sulfonilpirróis como inibidores de hdac

Info

Publication number: BRPI0909752A2
Authority: BR; Brazil
Prior art keywords: sulfonylpyrrols; production; hdac inhibitors; compound; meanings
Prior art date: 2008-03-12

Application number

BRPI0909752A

Other languages

English (en)

Inventor

Bernd Müller

Matthias Müller

Thomas Maier

Original Assignee

4Sc Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-12

Filing date

2009-03-11

Publication date

2015-10-06

2009-03-11 Application filed by 4Sc Ag filed Critical 4Sc Ag

2015-10-06 Publication of BRPI0909752A2 publication Critical patent/BRPI0909752A2/pt

2020-11-24 Publication of BRPI0909752B1 publication Critical patent/BRPI0909752B1/pt

2021-05-25 Publication of BRPI0909752B8 publication Critical patent/BRPI0909752B8/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
AIDS & HIV (AREA)
Hematology (AREA)
Psychology (AREA)
Otolaryngology (AREA)

BRPI0909752A 2008-03-12 2009-03-11 processos para a produção de sulfonilpirróis como inibidores de hdac e de uma composição farmacêutica compreendendo os mesmos BRPI0909752B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP08004567.7		2008-03-12
EP08004567A EP2100878A1 (en)	2008-03-12	2008-03-12	Novel method for the production of sulphonylpyrroles as HDAC inhibitors
PCT/EP2009/052870 WO2009112529A1 (en)	2008-03-12	2009-03-11	Novel method for the production of sulphonylpyrroles as hdac inhibitors

Publications (3)

Publication Number	Publication Date
BRPI0909752A2 true BRPI0909752A2 (pt)	2015-10-06
BRPI0909752B1 BRPI0909752B1 (pt)	2020-11-24
BRPI0909752B8 BRPI0909752B8 (pt)	2021-05-25

Family

ID=39639400

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909752A BRPI0909752B8 (pt)	2008-03-12	2009-03-11	processos para a produção de sulfonilpirróis como inibidores de hdac e de uma composição farmacêutica compreendendo os mesmos

Country Status (23)

Country	Link
US (1)	US8785659B2 (pt)
EP (2)	EP2100878A1 (pt)
JP (1)	JP5530939B2 (pt)
KR (1)	KR101571915B1 (pt)
CN (1)	CN101970404B (pt)
AT (1)	ATE519739T1 (pt)
AU (1)	AU2009224623C1 (pt)
BR (1)	BRPI0909752B8 (pt)
CA (1)	CA2719074C (pt)
CY (1)	CY1111994T1 (pt)
DK (1)	DK2265580T3 (pt)
EA (1)	EA017929B1 (pt)
ES (1)	ES2370592T3 (pt)
HK (1)	HK1150319A1 (pt)
IL (1)	IL207995A (pt)
MX (1)	MX2010010015A (pt)
NZ (1)	NZ587824A (pt)
PL (1)	PL2265580T3 (pt)
PT (1)	PT2265580E (pt)
SI (1)	SI2265580T1 (pt)
UA (1)	UA102091C2 (pt)
WO (1)	WO2009112529A1 (pt)
ZA (1)	ZA201006422B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2100882A1 (en) *	2008-03-12	2009-09-16	4Sc Ag	(E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
WO2017178577A1 (en)	2016-04-14	2017-10-19	4Sc Ag	Medical application of resminostat in asian patients
TW201912183A (zh)	2017-08-31	2019-04-01	德商４Ｓｃ製藥公司	Hdac抑制劑與抗代謝藥劑組合用於癌症治療

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4960787A (en)	1989-02-06	1990-10-02	Ciba-Geigy Corporation	Certain pyrrolyl-substituted hydroxamic acid derivatives
ATE156116T1 (de)	1991-12-10	1997-08-15	Shionogi & Co	Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
CA2223154A1 (en)	1995-06-02	1996-12-05	G.D. Searle & Co.	Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
NZ549251A (en)	2004-03-11	2010-05-28	4Sc Ag	Sulphonylpyrroles as HDAC inhibitors
MX2007010561A (es) *	2005-03-15	2008-02-22	Nycomed Gmbh	N-sulfonilpirroles y su uso como inhibidores de la histona desacetilasa.
BRPI0617167B8 (pt)	2005-09-21	2021-05-25	Nycomed Gmbh	sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação
NZ566073A (en)	2005-09-21	2011-08-26	4Sc Ag	Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors

2008
- 2008-03-12 EP EP08004567A patent/EP2100878A1/en not_active Ceased
2009
- 2009-03-11 AT AT09721108T patent/ATE519739T1/de active
- 2009-03-11 UA UAA201011865A patent/UA102091C2/ru unknown
- 2009-03-11 CN CN2009801082773A patent/CN101970404B/zh active Active
- 2009-03-11 PL PL09721108T patent/PL2265580T3/pl unknown
- 2009-03-11 BR BRPI0909752A patent/BRPI0909752B8/pt active IP Right Grant
- 2009-03-11 KR KR1020107020293A patent/KR101571915B1/ko active IP Right Grant
- 2009-03-11 JP JP2010550194A patent/JP5530939B2/ja active Active
- 2009-03-11 DK DK09721108.0T patent/DK2265580T3/da active
- 2009-03-11 EA EA201001270A patent/EA017929B1/ru not_active IP Right Cessation
- 2009-03-11 CA CA2719074A patent/CA2719074C/en active Active
- 2009-03-11 MX MX2010010015A patent/MX2010010015A/es active IP Right Grant
- 2009-03-11 EP EP09721108A patent/EP2265580B1/en active Active
- 2009-03-11 PT PT09721108T patent/PT2265580E/pt unknown
- 2009-03-11 ES ES09721108T patent/ES2370592T3/es active Active
- 2009-03-11 AU AU2009224623A patent/AU2009224623C1/en active Active
- 2009-03-11 US US12/921,928 patent/US8785659B2/en active Active
- 2009-03-11 NZ NZ587824A patent/NZ587824A/en unknown
- 2009-03-11 SI SI200930103T patent/SI2265580T1/sl unknown
- 2009-03-11 WO PCT/EP2009/052870 patent/WO2009112529A1/en active Application Filing
2010
- 2010-09-05 IL IL207995A patent/IL207995A/en active IP Right Grant
- 2010-09-07 ZA ZA2010/06422A patent/ZA201006422B/en unknown
2011
- 2011-06-08 HK HK11105798.0A patent/HK1150319A1/xx unknown
- 2011-11-03 CY CY20111101060T patent/CY1111994T1/el unknown

Also Published As

Publication number	Publication date
PT2265580E (pt)	2011-11-21
SI2265580T1 (sl)	2011-12-30
UA102091C2 (ru)	2013-06-10
EA017929B1 (ru)	2013-04-30
AU2009224623C1 (en)	2014-01-23
CA2719074A1 (en)	2009-09-17
CN101970404A (zh)	2011-02-09
EA201001270A1 (ru)	2011-04-29
DK2265580T3 (da)	2011-10-31
IL207995A0 (en)	2010-12-30
EP2100878A1 (en)	2009-09-16
AU2009224623B2 (en)	2013-07-18
KR20100121656A (ko)	2010-11-18
JP2011513467A (ja)	2011-04-28
BRPI0909752B8 (pt)	2021-05-25
CA2719074C (en)	2017-01-17
AU2009224623A1 (en)	2009-09-17
EP2265580A1 (en)	2010-12-29
US8785659B2 (en)	2014-07-22
HK1150319A1 (en)	2011-11-25
WO2009112529A1 (en)	2009-09-17
ES2370592T3 (es)	2011-12-20
IL207995A (en)	2013-04-30
CN101970404B (zh)	2013-05-08
NZ587824A (en)	2012-05-25
ATE519739T1 (de)	2011-08-15
KR101571915B1 (ko)	2015-11-25
US20110105568A1 (en)	2011-05-05
MX2010010015A (es)	2011-04-05
ZA201006422B (en)	2011-10-26
EP2265580B1 (en)	2011-08-10
BRPI0909752B1 (pt)	2020-11-24
CY1111994T1 (el)	2015-11-04
PL2265580T3 (pl)	2012-01-31
JP5530939B2 (ja)	2014-06-25

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-12-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-01-28	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-05-26	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-09-15	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-11-24	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/11/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

Publication	Publication Date	Title
FI3738434T3 (fi)	2023-11-20	Välituotteita substituoitujen bentsaldehydiyhdisteiden saamiseksi ja menetelmiä niiden käyttöön kudosten hapetuksen lisäämiseksi
EP2662352A3 (en)	2014-02-26	Method for Producing Phenylacetamide Compound
NZ594195A (en)	2013-04-26	N-acyl anthranilic acid derivative or salt thereof
MX2014006992A (es)	2014-08-01	Disales de acido malonico y metodo para preparar dihaluros de malonilo.
IT1392214B1 (it)	2012-02-22	Processo per la produzione di un composto dell'acido n-butirrico in forma microincapsulata, destinato ad alimentazione animale od umana
MX340125B (es)	2016-06-28	2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento.
MX2009003257A (es)	2009-04-07	Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
NZ601805A (en)	2014-07-25	Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
MY164641A (en)	2018-01-30	Use of sulphur-containing heteroaromatic acid analogues as bactericides
MX2023005704A (es)	2023-05-29	Metodo para manufacturar compuesto novedoso que contiene nitrogeno o sal del mismo e intermediario de manufacturacion del compuesto novedoso que contiene nitrogeno o sal del mismo.
CY1112520T1 (el)	2015-12-09	Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
MX2013012982A (es)	2013-12-06	Metodo para promover el crecimiento de plantas.
AR064658A1 (es)	2009-04-15	Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
WO2011098408A3 (de)	2011-11-03	Hydrazin-substituierte anthranilsäurederivate
PH12018500677A1 (en)	2018-10-15	Method for producing optically active 2- (2-fluorobiphenyl-4-yl) propanoic acid
ATE529413T1 (de)	2011-11-15	Verfahren zur synthese von aryloxydiaminopyrimidinen
AP2007004270A0 (en)	2007-12-31	Process for preparing salts of hydrocyanic acid
BRPI0909752A2 (pt)	2015-10-06	método para a produção de sulfonilpirróis como inibidores de hdac
MX354498B (es)	2018-03-08	Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.
BRPI0808570B8 (pt)	2021-05-25	processo para a preparação de inibidores de glyt-1
JO3189B1 (ar)	2018-03-08	طريقة جديدة لتخليق (e2) -3- (3, 4- داي ميثوكسي فينيل)بروب-2 - يننيتريل واستخدامها لتخليق ايفابرادين والاملاح المضافة منها مع حمض مقبول صيدلانيا
DE602005013007D1 (de)	2009-04-09	Verfahren zur herstellung von lactonen
UA111329C2 (uk)	2016-04-25	Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою
EA201400269A1 (ru)	2014-09-30	Способ синтеза соединений 7,8-диметокси -1,3-дигидро-2h-3-бензазепин-2-она и применение в синтезе ивабрадина
RU2007104626A (ru)	2008-08-27	Способ получения 5-ацетилсалицилоил-1,3,5-дитиазинана